We provide you with 20 years of free, institutional-grade data for LIVN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LIVN. Explore the full financial landscape of LIVN stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2024-02-29 | 1639691 | LIVN | 10-K | Url |
| 2023-11-01 | 1639691 | LIVN | 10-Q | Url |
| 2023-07-26 | 1639691 | LIVN | 10-Q | Url |
| 2023-05-03 | 1639691 | LIVN | 10-Q | Url |
| 2023-02-27 | 1639691 | LIVN | 10-K | Url |
| 2022-11-02 | 1639691 | LIVN | 10-Q | Url |
| 2022-08-03 | 1639691 | LIVN | 10-Q | Url |
| 2022-05-04 | 1639691 | LIVN | 10-Q | Url |
| 2022-03-01 | 1639691 | LIVN | 10-K | Url |
| 2021-11-03 | 1639691 | LIVN | 10-Q | Url |
| 2021-07-28 | 1639691 | LIVN | 10-Q | Url |
| 2021-04-28 | 1639691 | LIVN | 10-Q | Url |
| 2021-03-01 | 1639691 | LIVN | 10-K | Url |
| 2020-10-29 | 1639691 | LIVN | 10-Q | Url |
| 2020-07-29 | 1639691 | LIVN | 10-Q | Url |
| 2020-04-30 | 1639691 | LIVN | 10-Q | Url |
| 2020-03-02 | 1639691 | LIVN | 10-K | Url |
| 2019-10-30 | 1639691 | LIVN | 10-Q | Url |
| 2019-07-31 | 1639691 | LIVN | 10-Q | Url |
| 2019-05-01 | 1639691 | LIVN | 10-Q | Url |
| 2019-03-18 | 1639691 | LIVN | 10-K | Url |
| 2018-11-01 | 1639691 | LIVN | 10-Q | Url |
| 2018-08-02 | 1639691 | LIVN | 10-Q | Url |
| 2018-05-03 | 1639691 | LIVN | 10-Q | Url |
| 2018-02-28 | 1639691 | LIVN | 10-K | Url |
| 2017-11-02 | 1639691 | LIVN | 10-Q | Url |
| 2017-08-09 | 1639691 | LIVN | 10-Q | Url |
| 2017-05-03 | 1639691 | LIVN | 10-Q | Url |
| 2017-03-01 | 1639691 | LIVN | 10-K | Url |
| 2016-11-02 | 1639691 | LIVN | 10-Q | Url |
| 2016-08-05 | 1639691 | LIVN | 10-Q | Url |
| 2016-05-09 | 1639691 | LIVN | 10-Q | Url |
| 2015-12-02 | 1639691 | LIVN | 10-Q | Url |
| 2015-11-06 | 1639691 | LIVN | 10-Q | Url |
LivaNova PLC(NASDAQ:LIVN) 
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygena...
Website: http://www.livanova.com
Founded: 1987
Full Time Employees: 4,000
Sector: Healthcare
Industry: Medical Devices
The information provided in this report about LIVN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.